Juvenile OLFM4 Null Mice Are Protected from Sepsis.

Pediatric sepsis is a leading cause of morbidity and mortality in children. One of the most common and devastating morbidities is sepsis related acute kidney injury (AKI). AKI was traditionally thought to be related to low perfusion and acute tubular necrosis (ATN). However, little ATN can be found following septic AKI and little is known about the mechanism of septic AKI. Olfactomedin-4 (OLFM4) is a secreted glycoprotein that marks a subset of neutrophils. Increased expression of OLFM4 in the blood is associated with worse outcomes in sepsis. Here, we investigated a pediatric model of murine sepsis using murine pups to investigate the mechanisms of OLFM4 in sepsis. When sepsis was induced in murine pups, survival was significantly increased in OLFM4 null pups. Immunohistochemistry at 24 hours after induction of sepsis demonstrated increased expression of OLFM4 in the kidney, which was localized to the loop of Henle. Renal cell apoptosis and plasma creatinine were significantly increased in wild type versus OLFM4 null pups. Finally, bone marrow transplant suggested that increased OLFM4 in the kidney reflects local production rather than filtered from the plasma. These results demonstrate renal expression of OLFM4 for the first time and suggest a kidney-specific mechanism may contribute to survival differences in OLFM4 null animals.

[1]  Ó. Peñuelas,et al.  Histopathological changes of organ dysfunction in sepsis , 2019, Intensive Care Medicine Experimental.

[2]  M. Miyazaki,et al.  OLFM4 Enhances STAT3 Activation and Promotes Tumor Progression by Inhibiting GRIM19 Expression in Human Hepatocellular Carcinoma , 2019, Hepatology communications.

[3]  H. Wong,et al.  Olfactomedin 4 marks a subset of neutrophils in mice , 2018, Innate immunity.

[4]  M. van Meurs,et al.  Kidney histopathology in lethal human sepsis , 2018, Critical Care.

[5]  T. Kuijpers,et al.  Neutrophils as myeloid‐derived suppressor cells , 2018, European journal of clinical investigation.

[6]  P. Kubes,et al.  Neutrophil heterogeneity: Bona fide subsets or polarization states? , 2018, Journal of leukocyte biology.

[7]  P. Kubes.  The enigmatic neutrophil: what we do not know , 2018, Cell and Tissue Research.

[8]  H. Wong,et al.  Olfactomedin-4 Is a Candidate Marker for a Pathogenic Neutrophil Subset in Septic Shock , 2017, Critical care medicine.

[9]  R. Bellomo,et al.  Renal perfusion in sepsis: from macro- to microcirculation. , 2017, Kidney international.

[10]  Outcomes,et al.  Acute Kidney Injury in Pediatric Severe Sepsis: An Independent Risk Factor for Death and New Disability , 2016 .

[11]  R. Bellomo,et al.  Histopathology of Septic Acute Kidney Injury: A Systematic Review of Experimental Data , 2016, Critical care medicine.

[12]  J. Faith,et al.  Neutrophil ageing is regulated by the microbiome , 2015, Nature.

[13]  Rinaldo Bellomo,et al.  Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study , 2015, Intensive Care Medicine.

[14]  F. Staal,et al.  Olfactomedin 4 Serves as a Marker for Disease Severity in Pediatric Respiratory Syncytial Virus (RSV) Infection , 2015, PloS one.

[15]  E. Seeley,et al.  Increased expression of neutrophil-related genes in patients with early sepsis-induced ARDS. , 2015, American journal of physiology. Lung cellular and molecular physiology.

[16]  Derek Wheeler,et al.  Global epidemiology of pediatric severe sepsis: the sepsis prevalence, outcomes, and therapies study. , 2015, American journal of respiratory and critical care medicine.

[17]  H. Saito,et al.  A New Cecal Slurry Preparation Protocol with Improved Long-Term Reproducibility for Animal Models of Sepsis , 2014, PloS one.

[18]  Kiran Hebbar,et al.  Pediatric Severe Sepsis: Current Trends and Outcomes From the Pediatric Health Information Systems Database* , 2014, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[19]  Hans Clevers,et al.  Robust Cre-Mediated Recombination in Small Intestinal Stem Cells Utilizing the Olfm4 Locus , 2014, Stem cell reports.

[20]  J. Marshall.  Why have clinical trials in sepsis failed? , 2014, Trends in molecular medicine.

[21]  R. Hotchkiss,et al.  The changing immune system in sepsis , 2013, Virulence.

[22]  Wenli Liu,et al.  Olfm4 deletion enhances defense against Staphylococcus aureus in chronic granulomatous disease. , 2013, The Journal of clinical investigation.

[23]  A. Karlsson,et al.  The Human Neutrophil Subsets Defined by the Presence or Absence of OLFM4 Both Transmigrate into Tissue In Vivo and Give Rise to Distinct NETs In Vitro , 2013, PloS one.

[24]  Yueqin Liu,et al.  Olfactomedin 4 Inhibits Cathepsin C-Mediated Protease Activities, Thereby Modulating Neutrophil Killing of Staphylococcus aureus and Escherichia coli in Mice , 2012, The Journal of Immunology.

[25]  A. Silahtaroglu,et al.  Olfactomedin 4 defines a subset of human neutrophils , 2012, Journal of leukocyte biology.

[26]  Yi Huang,et al.  Depletion of OLFM4 gene inhibits cell growth and increases sensitization to hydrogen peroxide and tumor necrosis factor-alpha induced-apoptosis in gastric cancer cells , 2012, Journal of Biomedical Science.

[27]  Rajit K. Basu,et al.  Identification of candidate serum biomarkers for severe septic shock-associated kidney injury via microarray , 2011, Critical care.

[28]  B. Thornhill,et al.  Proximal tubular injury and rapid formation of atubular glomeruli in mice with unilateral ureteral obstruction: a new look at an old model. , 2011, American journal of physiology. Renal physiology.

[29]  P. Grover,et al.  Stem cell marker olfactomedin 4: critical appraisal of its characteristics and role in tumorigenesis , 2010, Cancer and Metastasis Reviews.

[30]  Yueqin Liu,et al.  Olfactomedin 4 down-regulates innate immunity against Helicobacter pylori infection , 2010, Proceedings of the National Academy of Sciences.

[31]  W. Mccune,et al.  IFNsVascular Damage and Synthesizes Type I Systemic Lupus Erythematosus Induces Neutrophils Isolated from Patients with A Distinct Subset of Proinflammatory , 2010 .

[32]  R. Bellomo,et al.  Pathophysiology of septic acute kidney injury: What do we really know? , 2008, Critical care medicine.

[33]  Wenli Liu,et al.  The glycoprotein hGC-1 binds to cadherin and lectins. , 2006, Experimental cell research.

[34]  R. Hotchkiss,et al.  The pathophysiology and treatment of sepsis. , 2003, The New England journal of medicine.